Cleerly LABS vs FEops HEARTguideTM

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cleerly
VS
by FEops nv

AI Verdict

Cleerly LABS is designed for the comprehensive analysis of coronary CT angiography to detect and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. In contrast, FEops HEARTguideTM focuses on pre-procedural planning for structural heart interventions like TAVI and LAAO, utilizing predictive simulations to optimize device sizing and positioning. Therefore, while both leverage AI and CT data in cardiology, they serve distinct clinical purposes: diagnosis and disease management versus interventional procedure planning.

Choose Cleerly LABS if…

Choose Cleerly LABS if your primary goal is to thoroughly assess and monitor coronary artery disease (CAD) through detailed plaque characterization and stenosis quantification from CCTA scans. This tool is ideal for identifying patients at risk, guiding medical management strategies, and tracking disease progression over time to personalize preventive care.

View Cleerly LABS →

Choose FEops HEARTguideTM if…

Choose FEops HEARTguideTM if you require advanced pre-procedural planning for complex structural heart interventions such as TAVI or LAAO. This platform excels at providing predictive simulations and precise anatomical measurements from CT scans to optimize device sizing, positioning, and overall procedural strategy, aiming to enhance patient outcomes.

View FEops HEARTguideTM →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly LABS FEops HEARTguideTM
Pricing Per analysis Contact for pricing
Deployment Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. Cloud-based
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cleerly LABS

Cleerly LABS is described as an interactive web-based software where trained medical professionals directly view, analyze, and edit segmentations of coronary CT angiography data. While FEops HEARTguide also offers an interactive viewer and manual measurement options, its service-based model implies that FEops prepares the initial analysis, potentially offering less direct user control over the core AI analysis process itself.

Clinical Value

Tie

Both tools offer significant and distinct clinical value. Cleerly LABS provides comprehensive diagnostic and prognostic insights for coronary artery disease, with strong clinical validation for ischemia detection and prediction of major adverse cardiovascular events. FEops HEARTguide significantly enhances the planning and outcomes of complex structural heart interventions like TAVI and LAAO through predictive simulations, demonstrating improved procedural efficiency and favorable clinical outcomes. Their contributions are equally impactful in different areas of cardiac care.

Pricing & Value

Cleerly LABS

Cleerly LABS provides transparent pricing information, including a per-analysis cost, retail price, and details on insurance coverage and potential out-of-pocket expenses. In contrast, FEops HEARTguide's pricing is not publicly disclosed, requiring direct contact for details, which makes it challenging for potential users to assess its value upfront.

Enterprise Readiness

FEops HEARTguideTM

Both tools are FDA-cleared, HIPAA compliant, and offer BAA, cloud-based deployment, and integration with clinical workflows. However, FEops HEARTguide explicitly mentions advanced security features like multi-factor authentication and enforced password changes, which are crucial for robust enterprise security and demonstrate a comprehensive approach to data protection within a hospital system.

Innovation

FEops HEARTguideTM

While Cleerly LABS is highly innovative with its AI-powered comprehensive plaque and ischemia analysis and has received multiple industry awards, FEops HEARTguide's 'digital twin' technology for predictive simulations in structural heart interventions represents a more novel and complex application of AI and computational modeling. This patient-specific virtual replica approach to simulate device-anatomy interaction for pre-operative planning is a cutting-edge advancement in personalized interventional cardiology.

Support & Docs

Cleerly LABS

Cleerly LABS provides clear information regarding its client support, including specific operating hours (Monday-Friday, 10 am ET to 6 pm ET) and a dedicated channel for existing users to request technical assistance. FEops HEARTguide mentions a support email and a 'Documentation' page, but lacks the specific details on availability and structured support processes that Cleerly offers.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly LABS FEops HEARTguideTM
Tool Name Cleerly LABS FEops HEARTguideTM
Company Cleerly FEops nv
Primary Focus / Use Case Comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. Structural heart procedure planning, providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO.
Key Technology AI-powered CCTA image analysis, comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with Cleerly ISCHEMIA module). AI and digital twin platform, predictive simulation technology for device-anatomy interaction, AI-based anatomical measurements from CT scans.
Data Integration Integration with PACS, RIS, EHR via Cleerly Proxy. DICOM interface for easy integration into clinical workflow.
Visualization Capabilities 3D visualization of coronary arteries. Interactive 2D and 3D viewer for detailed analysis, visualization and image reconstruction techniques (2D review, MPR).

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and FEops HEARTguideTM.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly LABS is an AI-powered software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. FEops HEARTguideTM is a cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO.
Cleerly LABS analyzes Coronary CT angiography (CCTA) images to provide comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, and ischemia detection. FEops HEARTguideTM uses CT scans to generate AI-based anatomical measurements, predictive simulations for device-anatomy interaction, and segmentation of cardiovascular structures for detailed analysis.
Cleerly LABS offers key features for tracking disease progression over time through its comprehensive coronary plaque assessment and personalized heart disease risk assessment. FEops HEARTguideTM provides predictive simulation technology and anatomical insights specifically to optimize device sizing and positioning for structural heart interventions.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.